Literature DB >> 13097987

Myleran in chronic myeloid leukaemia; results of treatment.

D A GALTON.   

Abstract

Entities:  

Keywords:  GLYCOLS/therapeutic use; LEUKEMIA, MYELOCYTIC/therapy

Mesh:

Substances:

Year:  1953        PMID: 13097987     DOI: 10.1016/s0140-6736(53)90885-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  40 in total

1.  [Long-term chemotherapy of chronic myeloid leukemia with Myleran and C69].

Authors:  H EHRHART
Journal:  Klin Wochenschr       Date:  1962-06-15

2.  [Studies on the problem of the genetic effectiveness of myleran on Drosophila melanogaster].

Authors:  G ROHRBORN
Journal:  Z Vererbungsl       Date:  1959

3.  Chemotherapy of cancer.

Authors:  K A NEWTON
Journal:  Postgrad Med J       Date:  1958-12       Impact factor: 2.401

4.  [Present status of chemotherapy in human neoplastic diseases].

Authors:  J PIRWITZ
Journal:  Klin Wochenschr       Date:  1957-05-01

5.  Treatment of chronic myeloid leukaemia with mercaptopurine.

Authors:  J R FOUNTAIN
Journal:  Br Med J       Date:  1956-12-08

6.  Myleran in treatment of chronic myeloid leukaemia.

Authors:  E K BLACKBURN; G M KING; H T SWAN
Journal:  Br Med J       Date:  1956-04-14

7.  The chemical control of cancer.

Authors:  J F HOLLAND
Journal:  Public Health Rep       Date:  1954-12       Impact factor: 2.792

8.  [The change of the effect of 1,4-butanediol by substitution to 1,4-butanediol dimethylsulfonyl ester (myleran)].

Authors:  V GLOMBITZA; A LOESER
Journal:  Klin Wochenschr       Date:  1954-09-01

9.  [The effect of myleran on the germ cells of rats].

Authors:  W BOLLAG
Journal:  Experientia       Date:  1953-07

Review 10.  A review of the role of the sequence-dependent electrostatic landscape in DNA alkylation patterns.

Authors:  Barry Gold; Luis M Marky; Michael P Stone; Loren D Williams
Journal:  Chem Res Toxicol       Date:  2006-11       Impact factor: 3.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.